Laura Rothuizen

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


47 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2008 | 2007 | 2006 | 2005 | 2003 | 1999 |
2023
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines.
Ekobena P., Rothuizen L.E., Bedussi F., Guilcher P., Meylan S., Ceschi A., Girardin F., Dao K., 2023/06. International journal of audiology, 62 (6) pp. 587-591. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2ACA564D1A62]
An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup.
Diezi L., Dao K., Jullien V., Roussel-Maupetit C., Burton I., André P., Bardinet C., Rothuizen L.E., Chtioui H., Manso-Silvan M.A. et al., 2023/02. Pharmacology research & perspectives, 11 (1) pp. e01032. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A3E445B0338]
Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others.
André P., Chtioui H., Dao K., Rothuizen L.E., Di Paolo E.R., Diezi M., Crisinel P.A., Cachat F., Chehade H., Buclin T., 2023/01. Kidney international, 103 (1) pp. 225-226. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E06602D511F4]
2022
Pharmacovigilance - Vaccins à ARNm contre le Covid-19 : le point sur les effets indésirables [Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects]
Favre V., Ekobena P., Chtioui H., Rothuizen L.E., Livio F., Genton B., Buclin T., 2022/02/02. Revue medicale suisse, 18 (767) pp. 190-197. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C87F5371DEBD]
 
Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
André P., Diezi L., Dao K., Crisinel P.A., Rothuizen L.E., Chtioui H., Decosterd L.A., Diezi M., Asner S., Buclin T., 2022. Frontiers in pediatrics, 9 p. 768438. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B465A6064AF2]
 
Safety, tolerability and pharmacokinetic profile of Macozinone (PBTZ169) formulated as native crystal powder: multiple ascendingdoses, phase-Ib trial in healthy volunteers
Chtioui H., Prod'Hom S., Desfontaine V., André P., Moulfi F., Bardinet C., Abo-Loha C., Tessieras J., Rothuizen L.E., Diezi L. et al., 2022. dans 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) - June 2022 Athens. European Journal of Clinical Pharmacology, 2022, 78: 1-163.
[serval:BIB_F1F116FD908F]
 
Safety, tolerability, pharmacokinetic profile and ex-vivo antitubercular acativity of macozinone formulated as spraydredi dispersion (SDD) versus native crystal powder (NCO?: single ascending doses, randomized, placebo-controlled, cross-ouver phase la trial in healthy volunteers
Rothuizen L.E., Ciullini L., Huser-Pitteloud J., Guidi M., Chtioui H., Ivanyuk A., André P., Bardinet C., Decosterd L.A., Spaggiari D. et al., 2022. dans SGAIM/SSMIG 6th Spring Congress Lausanne, June 2022. Primary and Hospital Care 2022: 22 (Suppl. 12), 173.
[serval:BIB_B502CD64B984]
2021
Médicaments, sexe et genre [Medicines, sex and gender]
Buclin T., Rothuizen L.E., Livio F., 2021/06/30. Revue medicale suisse, 17 (744-2) pp. 1262-1264. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CE0D6EEF8D5E]
 
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Pauliat E., Onken M., Weber-Schoendorfer C., Rousson V., Addor M.C., Baud D., Théaudin M., Diav-Citrin O., Cottin J., Agusti A. et al., 2021/03. Multiple sclerosis, 27 (3) pp. 475-478. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2D36E32A728F]
2020
 
Management of erroneous subcutaneous injection of vincristine.
de Goycoechea D., Dewarrat N., Rothuizen L.E., Matter M., Nagy M., Locher G., Spertini O., Blum S., 2020/10. Leukemia & lymphoma, 61 (10) pp. 2530-2532. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_641B75CE53D5]
Traitements aggravant une infection par le COVID-19 : vraiment ? [Drugs that aggravate the course of COVID-19 : really ?]
Rothuizen L.E., Livio F., Buclin T., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 852-854. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_460B9B6D3CDA]
2019
Infections aiguës des voies respiratoires et urinaires au cabinet médical : quelques traitements en médecine complémentaire [Acute respiratory and urinary tract infections in medical practice : a selection of complementary medicines]
Dumitrascu A., Senn L., Rothuizen L.E., Rodondi P.Y., 2019/04/24. Revue medicale suisse, 15 (648) pp. 875-881. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3233DE5CDE5B]
Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.
Jermini M., Dubois J., Rodondi P.Y., Zaman K., Buclin T., Csajka C., Orcurto A., Rothuizen L.E., 2019/03/25. Scientific reports, 9 (1) p. 5078. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EB0D132F2B63]
2018
 
Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.
Panchaud A., Rousson V., Vial T., Bernard N., Baud D., Amar E., De Santis M., Pistelli A., Dautriche A., Beau-Salinas F. et al., 2018/03. British journal of clinical pharmacology, 84 (3) pp. 568-578. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B81A0F10409F]
2016
 
Pregnancy outcome following maternal exposure to pregabalin may call for concern.
Winterfeld U., Merlob P., Baud D., Rousson V., Panchaud A., Rothuizen L.E., Bernard N., Vial T., Yates L.M., Pistelli A. et al., 2016/06/14. Neurology, 86 (24) pp. 2251-2257. Peer-reviewed.
[DOI][Pmid][serval:BIB_BAB64140AB78]
 
Pharmacovigilance [Pharmacovigilance update]
Dao K., Chtioui H., Rothuizen L.E., Diezi L., Prod'hom S., Winterfeld U., Buclin T., Livio F., 2016/01/13. Revue medicale suisse, 12 (500) pp. 75-79.
[Pmid][serval:BIB_61D54069EC5E]
2015
 
Des doutes insuffisants pour changer nos pratiques
Winterfeld Ursula, Baud David, Panchaud Alice, Rothuizen Laura, Livio Françoise, Stoller Rudolf, Buclin Thierry, 2015/10. Bulletin des médecins suisses, 96 (41) pp. 1494-1495.
[URN][DOI][serval:BIB_848AD57B1B48]
 
Multiplex Mass Spectrometry Analysis of Latest-Generation Antiepileptic Drugs: A Clinically Useful Laboratory Tool for Improved Real-Time Patients' Care.
Decosterd LA, Mercier T, André P, Bertholet S, Rothuizen LE, Rossetti AO, Buclin T, 2015/06. Epileptologie, 32 (2) pp. 85-89.
[serval:BIB_070F59406BE8]
 
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
Winterfeld U., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., Te Winkel B., Clementi M., Pistelli A., Maňáková E. et al., 2015/06. Journal of Clinical Psychopharmacology, 35 (3) pp. 250-259. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C8D9F29667C]
Atrophie de Lichtenberg post-vaccinale
Rochat Laurence, Gaide Olivier, Rothuizen Laura E., Genton Blaise, 2015/04/14. Forum Médical Suisse ‒ Swiss Medical Forum, 15 (16) pp. 350-352.
[URN][DOI][serval:BIB_C56D1C8F1B06]
 
Pharmacovigilance [Pharmacovigilance update].
Fogarasi Szabo N., Diezi L., Delenclos L., Renard D., Chtioui H., Rothuizen L.E., Buclin T., Livio F., 2015/01. Revue Médicale Suisse, 11 (456-457) pp. 124-128.
[URN][Pmid][serval:BIB_D8A2874AB9AF]
 
Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
Weber-Schoendorfer C., Oppermann M., Wacker E., Bernard N., network of French pharmacovigilance centres, Beghin D., Beghin D., Cuppers-Maarschalkerweerd B., Richardson J.L., Rothuizen L.E. et al., 2015. British Journal of Clinical Pharmacology, 80 (4) pp. 727-739. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_836106A36BE1]
Spectrum of digoxin-induced ocular toxicity: a case report and literature review.
Renard D., Rubli E., Voide N., Borruat F.X., Rothuizen L.E., 2015. Bmc Research Notes, 8 (1) p. 368. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_08D50AFE3918]
 
Therapeutic Drug Monitoring of Antiepileptic Drugs in the 21st Century
André P., Novy J., Decosterd LA, Buclin T., Rothuizen LE, 2015/01/01. Epileptologie 32 pp. 78-84.
[serval:BIB_563351C391E5]
2014
Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft : Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand [Antiepileptics in women of childbearing age and during pregnancy : Comparison of specialized information with the current state of knowledge in Germany and Switzerland].
Winterfeld U., Gotta V., Rothuizen L.E., Panchaud A., Rossetti A.O., Buclin T., 2014. Der Nervenarzt, 85 (6) pp. 738-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_72BDC14B7721]
 
Perampanel: a significant liver enzyme inducer in some patients?
Novy J., Rothuizen L.E., Buclin T., Rossetti A.O., 2014. European Neurology, 72 (3-4) pp. 213-216. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_73F938A4F28D]
 
Pharmacovigilance [Pharmacovigilance update].
Diezi L., Renard D., Rothuizen L.E., Livio F., 2014. Revue Médicale Suisse, 10 (412-413) pp. 119-122.
[Pmid][serval:BIB_12B1E6FE7B5D]
2013
 
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (11) p. 1440.
[DOI][WoS][Pmid][serval:BIB_ECF16CE99D2A]
Pregnancy outcome following maternal exposure to Mirtazapine: Preliminary results of a collaborative ENTIS study.
Winterfeld U., Buclin T., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., te Winkel B., Clementi M., Pistelli A. et al., 2013. pp. e1-e2 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
[URN][serval:BIB_26030447190E]
 
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L.E., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (4) pp. 463-471. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_76900E4385FF]
2012
 
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.
Panchaud A., Csajka C., Merlob P., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G. et al., 2012. Journal of Clinical Pharmacology, 52 (12) pp. 1844-1851. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A2D63B38436E]
2010
 
Pharmacovigilance update [Pharmacovigilance update]
Livio F., Ivanyuk A., Biollaz J., Rothuizen L., Buclin T., 2010. Revue Médicale Suisse, 6 (232) pp. 128-131.
[Pmid][serval:BIB_6D790D62BAB3]
 
Pregnancy outcome after maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A., Berlin M. et al., 2010. dans 21st Annual Meeting of the European Network Teratogen Information Services (ENTIS).
[serval:BIB_A6F9F6CDE49A]
2008
 
Les risques liés à l'utilisation des rétinoïdes topiques pendant la grossesse
Panchaud A., Stah B., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G., Rothuizen L.E. et al., 2008. Tribune médicale = Medical Tribune, 14 (Mai 21-22) p. 11.
[serval:BIB_7CB319A8DBDE]
 
Médicaments et allaitement: quelques éléments a considérer avant de les juger incompatibles [Drugs and breastfeeding: some facts to consider before deciding they are incompatible]
Panchaud A., Fischer C., Rothuizen L., Buclin T., 2008. Revue Médicale Suisse, 4 (146) pp. 540-545.
[Pmid][serval:BIB_8016F6851F68]
 
Médicaments et allaitement: quelques éléments à considérer avant de les juger incompatibles [Drugs and breastfeeding: some facts to consider before deciding they are incompatible]
Panchaud A., Fischer C., Rothuizen L., Buclin T., 2008. Revue Médicale suisse, 4 (146) pp. 540-545.
[Pmid][serval:BIB_D2B0759CD078]
2007
 
Effect of dronedarone on renal function in healthy subjects.
Tschuppert Y., Buclin T., Rothuizen L.E., Decosterd L.A., Galleyrand J., Gaud C., Biollaz J., 2007. British Journal of Clinical Pharmacology, 64 (6) pp. 785-791. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29365D442E7A]
2006
 
Ne pas negliger le risque de surtraitement: l'exemple des antiepiteptiques. [Risk of overtreatment: not to be neglected. The example of antiepileptic drugs]
Rothuizen L. E., Buclin T., Reichhart M., Biollaz J., 2006/04. Revue Médicale Suisse, 2 (61) pp. 976-80.
[Pmid][serval:BIB_CDD994234E2B]
 
Attitude de prescription chez la femme enceinte : exemple de prise en charge d'un état dépressif
Panchaud A., Rothuizen L.E., Buclin T., 2006. Swiss Medical Forum = Forum Médical Suisse, 6 (43) pp. 961-964. Peer-reviewed.
[serval:BIB_F9F8EB1B65FD]
 
Effets du cannabis oral et du dronabinol sur la capacité à conduire [Effects of oral cannabis and dronabinol on driving capacity]
Giroud C., Augsburger M., Favrat B., Menetrey A., Pin M.A., Rothuizen L.E., Appenzeller M., Buclin T., Mathieu S., Castella V. et al., 2006. Annales Pharmaceutiques Françaises, 64 (3) pp. 161-172.
[Pmid][serval:BIB_85D07622711E]
 
Exposition intra-utérine aux SSRI et syndrome de sevrage néonatal : un recensement des mères traitées et un suivi du développement psychomoteur de l'enfant sont-ils nécessaires?
Jequier M., Rothuizen L.E., Buclin T., Hohlfeld P., Tolsa J.F., Tabin R., 2006. Paediatrica : Bulletin der Schweizerischen Gesellschaft für Pädiatrie (SGP) = Bulletin de la Société suisse de pédiatrie (SSP), 17 (4) pp. 34-37.
[serval:BIB_1DAD27703468]
 
Malformations cardiaques congénitales sous paroxétine
Panchaud A., Rothuizen L.E., Buclin T., 2006. Journal Suisse de Pharmacie, 144 (8) pp. 292-295.
[serval:BIB_F6F973A994E2]
 
Troubles anxieux provoqués par le cannabis: sont-ils explicables par des différences de métablisme ou par une vulnérabilité génétique différenciée aux effets psychotropes des cannabinoïdes
Giroud C., Castella V., Favrat B., Rothuizen L.E., Appenzeller M., Buclin T., Mangin P., Augsburger M., 2006. Annales de Toxicologie Analytique, XVIII (3) pp. 185-186. Peer-reviewed.
[serval:BIB_11D814EDF229]
2005
Two cases of "cannabis acute psychosis" following the administration of oral cannabis.
Favrat B., Ménétrey A., Augsburger M., Rothuizen L.E., Appenzeller M., Buclin T., Pin M., Mangin P., Giroud C., 2005/04/01. BMC psychiatry, 5 p. 17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50A330F58CDE]
Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A., Augsburger M., Favrat B., Pin M.A., Rothuizen L.E., Appenzeller M., Buclin T., Mangin P., Giroud C., 2005. Journal of Analytical Toxicology, 29 (5) pp. 327-338. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A94B2E9DBD5F]
2003
A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes.
Barbey F., Bonny O., Rothuizen L., Gomez F., Burnier M., 2003. Nephrology, Dialysis, Transplantation, 18 (10) pp. 2193-2196.
[URN][DOI][WoS][Pmid][serval:BIB_FDB08EEB13B0]
1999
 
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers.
Rothuizen L.E., Buclin T., Spertini F., Trinchard I., Munafo A., Buchwalder P.A., Ythier A., Biollaz J., 1999. Journal of Neuroimmunology, 99 (1) pp. 131-141.
[DOI][WoS][Pmid][serval:BIB_A108268603FA]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University